1. Why you should watch Zubin Damania innovate healthcare
You may not know the name of one of the most talented and innovative forces in healthcare but there is a high probability that you have seen one of his video parodies about health. This is because Zubin Damania, M.D., goes under the alter ego ZDogg MD.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
2. How will wearables impact the consumer healthcare marketplace?
The human body produces a staggering amount of data 24 hours a day, 7 days a week, 365 days a year (and 366 days in a leap year ?). We are only at the beginning of a journey to help us understand the impact of activities, sleep, temperature, perspiration and other data points of the human body, with over 100 different wearable devices available in today’s marketplace to monitor our health and fitness.
3. A digital health dilemma: How healthcare ruins text messaging
I am known by my patients and friends for my calm, imperturbable manner. Yes, I am equipped with the full range of human emotions, but few folks have ever seen me raise my voice or demonstrate bulging next veins. I am not suggesting this is a virtue or a character flaw, but is just the way I am wired.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Stealth Bay Area medical device maker Cala Health looks to have closed out an $18 million Series A round, according to a regulatory filing. Investors in the company include Johnson & Johnson Development Corporation, Lux Capital and Lightstone Ventures.
The Stanford University spinout, founded in 2014, is simply saying on its website that it’s developing “novel therapies based on recent neuroscience discoveries.” However, an alumni briefing from the Stanford Biodesign program says a little more: That it’s building a minimally invasive “wearable therapy for hand tremor.”
5. IBM Watson Health ups ante in Big Data with $2.6B Truven acquisition
IBM Watson Health has fired the latest shot in a budding healthcare Big Data arms race. Big Blue announced Thursday that it would acquire Ann Arbor, Mich.-based Truven Health Analytics for an attention-getting $2.6 billion.
This deal gives IBM access to 4 petabytes of healthcare claims and administrative data, as well as Truven’s roster of hundreds of scientists. “It’s not just about the data. It’s about expertise,” said Dr. Anil Jain, vice president of IBM Watson Health.
